Journal of Young Pharmacists logo
Review

Carbamazepine and its Synthesis Related Impurities Profile Compilation and its Monograph Dispute for the Best Regulatory Practice: A Review

1, 1★, 1★ Corresponding author

  1. 1Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, INDIA.

CORRESPONDENCE

Jeyaprakash Mari Raju

Department of Pharmaceutical Analysis, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Ooty, Nilgiris, Tamil Nadu, INDIA.

jpvis7@jssuni.edu.in

Received: 15-09-2020; Revised: 11-10-2020; Accepted: 13-11-2020.

Volume 12, Issue 4 · pp. 294-298 · 2020 · DOI: 10.5530/jyp.2020.12.80

ABSTRACT

Carbamazepine (CBZ) is a widely-used anticonvulsant drug, with a high prescription rate. However, there seem to be certain inconsistencies regarding the number of reported impurities of the drug. A monograph study of the drug reveals the difference in the numbers of reported impurities of the drug, i.e., different monographs have reported dissimilar number of impurities for the same drug. Literature survey reveals that over 10 routes of synthesis are currently existing for the synthesis of CBZ, as well as employing over 25 reactants across the synthetic routes. There also appears to be a lack of mention of the number of carcinogenic impurities of the drug. This review article aims to summarize the potential for the presence of potential carcinogenic impurities and its carcinogenicity in the drug of CBZ. Which can arise from the various reactants involved in the manufacturing process of the drug and their individual role in imparting carcinogenicity to the final formulation.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Debnath, S., Raju, J. M., & Chennapragada, R. S. (2020). Carbamazepine and its Synthesis Related Impurities Profile Compilation and its Monograph Dispute for the Best Regulatory Practice: A Review. Journal of Young Pharmacists, 12(4), 294-298. https://doi.org/10.5530/jyp.2020.12.80

    Copyright and licence

    © 2020 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0